Rankings
▼
Calendar
MNKD
MannKind Corporation
$841M
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$5M
Operating Income
-$20M
Net Income
-$25M
EPS (Diluted)
$-0.29
Cash Flow
Operating Cash Flow
-$31M
Free Cash Flow
-$32M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$93M
Total Liabilities
$467M
Stockholders' Equity
-$373M
Cash & Equivalents
$28M
← FY 2016
All Quarters
Q2 2016 →
MNKD Q1 2016 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena